EUVIMED · CrossrefJournal
Cancer Research Communications
ISSN 2767-9764 · American Association for Cancer Research (AACR)
Latest articles
Combined immune-related adverse events and prognosis in advanced melanoma patients treated with immune checkpoint inhibitors: VigiBase and RIC-Mel data analysis
Nerve proximity and high endothelial venules mark tertiary lymphoid structure niches associated with survival in advanced pancreatic cancer: an autopsy study
Cardiopulmonary Fitness and Neurocognitive Function in Long-term Childhood Hodgkin Lymphoma Survivors
Resistance to first-generation TRK inhibitor therapy in NTRK fusion-positive adult and pediatric cancers conditions next-generation TRK inhibitor activity: a phase I study of selitrectinib
Tissue factor-specific sdAb radiotracers for molecular imaging in solid tumors
Primary mediastinal large B-cell lymphoma genomic profiling demonstrates thymic B-cell identity and frequent aberrant somatic hypermutation
Social vulnerability index associates with chronic lymphocytic leukemia survival rates in the Detroit tri-county area
Irradiation induces an epigenetically plastic CD44low persister cell population associated with tumor regrowth in colorectal cancer
Distinguishing Features of Radiation-Induced from Sporadic Thyroid Cancers after the Chornobyl Nuclear Power Plant Accident
Combination Therapy with AKT and MEK Inhibitors is Effective in Patient-Derived Models of Adrenocortical Carcinoma
A Phase 1 Trial of Low-dose Gemcitabine Combined with ATR Inhibitor Elimusertib for Advanced Solid Tumors
A Practical Guide to Choosing Multiple-Comparison Tests for Efficacy Analysis in Small-Sample Patient-Derived Xenograft Studies
MicroRNA Expression in Macrophages Regulates Antibody-Dependent Effector Function and B-cell Lymphoma Therapy
Comparative Analysis of Ovarian Cancer Tumor-Infiltrating T Cells with Those in Melanoma and before and after PD-1 Blockade
Cancer Cell CD73 Loss Promotes a Dual Inflammatory and Immunosuppressive Microenvironment in Endometrial Carcinoma
The Use of TF-Ag-α to Selectively Capture Tumor-Derived Extracellular Vesicles and Enhance the Predictive Performance of Extracellular Vesicle PD-L1 for Response to Immune Checkpoint Inhibitors
Androgen-Mediated T-cell Suppression Drives Sex Bias in Head and Neck Squamous Cell Carcinoma
Prognostic Modeling Integrating RAS and SMAD4 Status in Patients with BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer
Biomarker Modulation by Aspirin and Metformin for Colorectal Cancer Prevention: Results from the ASAMET Randomized Phase II Trial
Paxalisib with Trastuzumab for HER2-Positive Metastatic Breast Cancer with Active Brain Metastases: A Phase II Trial with Integrated Plasma and CSF ctDNA Analyses
MCL1 may not mediate chemoresistance in cancer cells
Mechanisms of pregnancy-associated triple negative breast cancer risk: insights from spatial omics
A First-in-Human, Phase I Trial of MK-6598, an Inhibitor of the Immune Checkpoint IL4I1, With or Without Pembrolizumab for Advanced Solid Tumors
Anti–PD-L1 glycoengineering enhances tumor killing through coordinated interactions between PD-L1⁺ DCs and CD16A⁺ cytotoxic lymphocytes
Elucidating the Gene Expression Signature of Rosai–Dorfman Disease: A Study from the Atlas of Blood Cancer Genomes Initiative
ERX-208 Induces Endoplasmic Reticulum Stress and Suppresses DNA Damage Repair to Enhance Chemotherapy Sensitivity
Targeting PRMT5 Inhibitor–Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam
Improving Long-Read Somatic Structural Variant Calling with Pangenome and De Novo Personal Genome Assembly
Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
Glioblastoma Subtypes Exhibit Distinct Migration Mechanics and Immune Responses
EUVIMED